Bactrim: Potent Dual-Action Antibiotic for Bacterial Infections
| Product dosage: 480mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.46 | $41.10 (0%) | 🛒 Add to cart |
| 120 | $0.42 | $54.81 $50.13 (9%) | 🛒 Add to cart |
| 180 | $0.38 | $82.21 $68.17 (17%) | 🛒 Add to cart |
| 270 | $0.36 | $123.31 $97.25 (21%) | 🛒 Add to cart |
| 360 | $0.34
Best per pill | $164.42 $121.31 (26%) | 🛒 Add to cart |
Bactrim is a powerful, combination antibiotic medication containing sulfamethoxazole and trimethoprim. It operates through a synergistic dual-mechanism action, effectively inhibiting successive steps in bacterial folate synthesis, which is crucial for DNA and protein production. This makes it a formidable opponent against a wide spectrum of susceptible bacteria, commonly prescribed for everything from urinary tract infections to certain types of pneumonia. Its reliability and broad-spectrum efficacy have established it as a cornerstone in antimicrobial therapy for decades.
Features
- Contains a fixed-dose combination of 800 mg sulfamethoxazole and 160 mg trimethoprim
- Available in oral tablet and oral suspension formulations
- Functions as a bacteriostatic agent, inhibiting bacterial growth
- Double-blockade mechanism targets dihydrofolic acid synthesis
- Standard packaging in bottles of 100, 500, and unit-dose blister packs
- Requires a prescription in most jurisdictions
Benefits
- Effectively treats a wide range of bacterial infections due to its broad-spectrum activity
- Dual-action mechanism reduces the likelihood of rapid bacterial resistance development
- Convenient twice-daily dosing regimen supports patient adherence to treatment
- Proven efficacy in both community-acquired and opportunistic infections
- Available in multiple formulations to accommodate different patient needs, including pediatric suspension
- Cost-effective treatment option compared to many newer antibiotics
Common use
Bactrim is commonly prescribed for the treatment of urinary tract infections, including cystitis and pyelonephritis, caused by susceptible strains of Escherichia coli, Klebsiella species, and Enterobacter species. It is also indicated for acute exacerbations of chronic bronchitis in adults, due to susceptible strains of Haemophilus influenzae and Streptococcus pneumoniae. Additionally, Bactrim finds application in the management of traveler’s diarrhea caused by enterotoxigenic E. coli, and is used for the treatment and prophylaxis of Pneumocystis jirovecii pneumonia in immunocompromised patients, particularly those with HIV/AIDS. Off-label uses may include treatment of certain skin and soft tissue infections, otitis media, and shigellosis, when caused by susceptible organisms.
Dosage and direction
For most infections in adults and children over 12 years, the usual adult dosage is one DS (double strength) tablet (800 mg sulfamethoxazole/160 mg trimethoprim) every 12 hours. For children aged 2 months to 12 years, the recommended dosage is based on body weight: 8-10 mg/kg trimethoprim and 40-50 mg/kg sulfamethoxazole per 24 hours, administered in two divided doses every 12 hours. The duration of treatment typically ranges from 10 to 14 days for most infections, but may be extended for severe or complicated infections. For Pneumocystis jirovecii pneumonia treatment, the dosage is typically 15-20 mg/kg trimethoprim and 75-100 mg/kg sulfamethoxazole per 24 hours in divided doses every 6-8 hours. Tablets should be taken with a full glass of water, and the oral suspension should be shaken well before each use. Patients are advised to maintain adequate fluid intake to prevent crystalluria and stone formation.
Precautions
Patients should be cautioned about maintaining adequate hydration during therapy to prevent crystalluria. Regular monitoring of complete blood counts is recommended during prolonged therapy, as hematologic changes may occur. Those with impaired renal or hepatic function require dosage adjustment and close monitoring. Patients should be advised that Bactrim may cause photosensitivity reactions, necessitating sun protection measures. Those with glucose-6-phosphate dehydrogenase deficiency should use with extreme caution due to risk of hemolysis. Elderly patients may be more susceptible to severe adverse reactions, particularly those affecting the skin and blood. Regular renal function tests are advised during extended therapy. Patients should be informed that Bactrim may interfere with certain laboratory tests, including serum methotrexate assays and Jaffe’s reaction for creatinine measurement.
Contraindications
Bactrim is contraindicated in patients with known hypersensitivity to sulfonamides, trimethoprim, or any component of the formulation. It should not be used in patients with documented megaloblastic anemia due to folate deficiency. Contraindications include severe hepatic damage, marked renal impairment (creatinine clearance below 15 mL/min), and infants less than 2 months of age. The medication is also contraindicated in pregnant women at term and nursing mothers because sulfonamides may cause kernicterus in newborns. Patients with history of drug-induced immune thrombocytopenia with sulfonamides or trimethoprim should not receive Bactrim.
Possible side effect
Common side effects include nausea, vomiting, loss of appetite, and mild diarrhea. Dermatological reactions may occur, ranging from rash and urticaria to more severe manifestations like Stevens-Johnson syndrome or toxic epidermal necrolysis. Hematologic effects can include leukopenia, neutropenia, thrombocytopenia, and megaloblastic anemia. Hepatic reactions may manifest as elevated transaminases, hepatitis, or cholestatic jaundice. Renal effects might include interstitial nephritis, elevated creatinine, or crystalluria. Neurological effects can include headache, dizziness, and insomnia. Other potential side effects include fungal overgrowth, photosensitivity reactions, and electrolyte disturbances such as hyperkalemia, particularly in patients with renal impairment or those taking other medications that affect potassium levels.
Drug interaction
Bactrim may potentiate the effects of warfarin and other oral anticoagulants, requiring close monitoring of prothrombin time. It may increase concentrations of phenytoin, sulfonylureas, and methotrexate, potentially leading to toxicity. Concurrent use with angiotensin-converting enzyme inhibitors or potassium-sparing diuretics may increase the risk of hyperkalemia. Bactrim may decrease the efficacy of oral contraceptives, necessitating additional contraceptive measures. It can enhance the hypoglycemic effect of sulfonylureas and may increase the risk of cyclosporine nephrotoxicity. Concurrent administration with drugs that cause bone marrow suppression may increase hematologic toxicity. Bactrim may interfere with the metabolism of tricyclic antidepressants and certain antipsychotic medications.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed one. Maintaining consistent blood levels is important for effectiveness, so establishing a routine for medication administration is recommended. If multiple doses are missed, patients should contact their healthcare provider for guidance on how to proceed with treatment.
Overdose
Symptoms of overdose may include nausea, vomiting, dizziness, headache, mental depression, confusion, and bone marrow depression. In severe cases, jaundice, crystalluria, hematuria, or electrolyte abnormalities may occur. Management involves gastric lavage if ingestion was recent, along with supportive measures and correction of fluid and electrolyte imbalances. Urinary alkalinization may help prevent crystall formation and enhance elimination. Hemodialysis may be moderately effective in removing both components, particularly in patients with renal impairment. Blood counts should be monitored, and folinic acid (leucovorin) may be administered in cases of significant bone marrow suppression.
Storage
Store at room temperature between 15-30°C (59-86°F) in a tightly closed container. Protect from light and moisture. Keep the oral suspension tightly closed and shake well before each use. Do not freeze. Keep all medications out of reach of children and pets. Do not store in bathroom cabinets where moisture levels fluctuate. Discard any unused oral suspension after the expiration date or if it shows signs of deterioration. Do not flush medications down the toilet or pour them into drainage unless instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any new medication or making changes to existing treatment. The information provided here may not cover all possible uses, directions, precautions, or interactions. Individual patient responses to medication may vary. Healthcare providers should be informed of complete medical history and all medications being taken, including prescription drugs, over-the-counter medications, and herbal supplements.
Reviews
Clinical studies have demonstrated Bactrim’s efficacy in treating susceptible infections, with success rates typically exceeding 85% for uncomplicated urinary tract infections. Many physicians appreciate its broad-spectrum coverage and cost-effectiveness. However, some note the increasing resistance patterns in certain geographic areas. Patient reviews often mention effectiveness in resolving infections but sometimes report gastrointestinal side effects. The medical community generally considers Bactrim a valuable antibiotic when used appropriately for susceptible organisms, though careful patient selection and monitoring are emphasized due to potential adverse effects.